Cargando…

Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations

We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelan, David, Prado-Cabrero, Alfonso, Nolan, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691749/
https://www.ncbi.nlm.nih.gov/pubmed/29039801
http://dx.doi.org/10.3390/nu9101133
_version_ 1783279854745026560
author Phelan, David
Prado-Cabrero, Alfonso
Nolan, John M.
author_facet Phelan, David
Prado-Cabrero, Alfonso
Nolan, John M.
author_sort Phelan, David
collection PubMed
description We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared concentrations of these nutrients i.e., lutein (L) zeaxanthin (Z) and meso-zeaxanthin (MZ) in commercially available supplements. Since this publication, we performed further analyses using different commercially available macular carotenoid supplements. Three capsules from one batch of eight products were analysed at two different time points. The results have been alarming. All of the powder filled products (n = 3) analysed failed to comply with their label claim (L: 19–74%; Z: 57–73%; MZ: 83–97%); however, the oil filled soft gel products (n = 5) met or were above their label claim (L: 98–122%; Z: 117–162%; MZ: 97–319%). We also identified that the carotenoid content of the oil filled capsules were stable over time (e.g., L average percentage change: −1.7%), but the powder filled supplements degraded over time (e.g., L average percentage change: −17.2%). These data are consistent with our previous work, and emphasize the importance of using carotenoid interventions in oil based formulas rather than powder filled formulas.
format Online
Article
Text
id pubmed-5691749
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56917492017-11-22 Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations Phelan, David Prado-Cabrero, Alfonso Nolan, John M. Nutrients Article We previously identified that the concentration of zeaxanthin in some commercially available carotenoid supplements did not agree with the product’s label claim. The conclusion of this previous work was that more quality assurance was needed to guarantee concordance between actual and declared concentrations of these nutrients i.e., lutein (L) zeaxanthin (Z) and meso-zeaxanthin (MZ) in commercially available supplements. Since this publication, we performed further analyses using different commercially available macular carotenoid supplements. Three capsules from one batch of eight products were analysed at two different time points. The results have been alarming. All of the powder filled products (n = 3) analysed failed to comply with their label claim (L: 19–74%; Z: 57–73%; MZ: 83–97%); however, the oil filled soft gel products (n = 5) met or were above their label claim (L: 98–122%; Z: 117–162%; MZ: 97–319%). We also identified that the carotenoid content of the oil filled capsules were stable over time (e.g., L average percentage change: −1.7%), but the powder filled supplements degraded over time (e.g., L average percentage change: −17.2%). These data are consistent with our previous work, and emphasize the importance of using carotenoid interventions in oil based formulas rather than powder filled formulas. MDPI 2017-10-17 /pmc/articles/PMC5691749/ /pubmed/29039801 http://dx.doi.org/10.3390/nu9101133 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Phelan, David
Prado-Cabrero, Alfonso
Nolan, John M.
Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title_full Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title_fullStr Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title_full_unstemmed Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title_short Stability of Commercially Available Macular Carotenoid Supplements in Oil and Powder Formulations
title_sort stability of commercially available macular carotenoid supplements in oil and powder formulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691749/
https://www.ncbi.nlm.nih.gov/pubmed/29039801
http://dx.doi.org/10.3390/nu9101133
work_keys_str_mv AT phelandavid stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations
AT pradocabreroalfonso stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations
AT nolanjohnm stabilityofcommerciallyavailablemacularcarotenoidsupplementsinoilandpowderformulations